Efficient and accurate liquid handling techniques are essential components of a wide range of research applications such as immunoassays and drug development. Maintenance of high quality of liquid handling is imperative for consistent and reliable results. ALH systems are equipment that are precisely programmed to handle liquids and deliver accurate and reproducible results without any complexity in clinical and research settings. The global ALH market accounted for $585 million in 2016, and is estimated to reach at $1,054 million by 2023, registering a CAGR of 8.7% from 2017 to 2023.
Profits and productivity of clinical laboratories and contract research organizations are based on the number of processed samples in the diagnostics industry; hence, high throughput analysis is crucial in such processes. Automated liquid handling offers high throughput processing at the expense of reduced labor costs, streamlined workflow, decreased manual errors, and improved overall experiment outcome.
The global ALH market is driven by advancement in plastic molding technology, technological advancements associated with ALH systems, and advantages of ALH systems over manual pipetting. In addition, rise in awareness of the benefits of using ALH is expected to fuel the market growth. However, high costs of instruments and complex operability of advanced ALH systems are expected to hamper the market growth. Furthermore, untapped potential of emerging markets provides lucrative opportunities to the market players.
The automated liquid handling market is segmented based on type, modality, end user, and geography. Based on type, it is divided into standalone, individual benchtop workstation, multi-instrument system, and others. On the basis of modality, it is bifurcated into fixed tips and disposable tips. Based on procedure, it is divided into PCR setup, serial dilution, high-throughput screening, cell culture, whole genome amplification, plate reformatting, array printing, and other procedures. On the basis of end user, it is classified into biotechnology & pharmaceutical company, contract research organization, academic & government research institute. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
KEY PLAYERS PROFILED
KEY MARKET SEGMENTS
By End User
The other players in the value chain include (profiles not included in the report)
The Global Cetirizine Hydrochloride market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Cetirizine Hydrochloride market, especially in North America, Europe, Asia-Pacific, South America, Middle ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and Philippines, focuses ...
November 2017 | $4660 |View Details>>
In 2016, the Cetirizine Hydrochloride market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include UCB Pharma Pfizer J ...
November 2017 | $3360 |View Details>>
In 2016, the Europe Cetirizine Hydrochloride market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Cetirizine Hydrochloride in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in ...
November 2017 | $4660 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research